Risk Stratification and Treatment of Obesity for Primary and Secondary Prevention of Cardiovascular Disease

被引：0
|
作者：
John W. Ostrominski
Tiffany M. Powell-Wiley
机构：
[1] Brigham and Women’s Hospital and Harvard Medical School,Division of Cardiovascular Medicine
[2] Brigham and Women’s Hospital and Harvard Medical School,Division of Endocrinology, Diabetes and Hypertension
[3] National Heart,Social Determinants of Obesity and Cardiovascular Risk Laboratory, Cardiovascular Branch, Division of Intramural Research
[4] Lung and Blood Institute,Intramural Research Program
[5] National Institutes of Health,undefined
[6] National Institute on Minority Health and Health Disparities,undefined
[7] National Institutes of Health,undefined
来源：
Current Atherosclerosis Reports | 2024年 / 26卷
关键词：
Obesity; Cardiometabolic disease; Prevention; Weight management; Social determinants of health; Pharmacotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 23
页数：12
相关论文
共 50 条
  • [31] Primary and secondary prevention of cardiovascular disease in diabetes with aspirin
    Ajjan, Ramzi A.
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (04): : 243 - 244
  • [32] Platelet inhibitors in primary and secondary prevention of cardiovascular disease
    Huber, K.
    Jaeger, B.
    Kaufmann, C. C.
    JOURNAL FUR KARDIOLOGIE, 2019, 26 (11-12): : 312 - 316
  • [33] A telemonitoring program for primary and secondary prevention of cardiovascular disease
    Lupi, L.
    Glisenti, F.
    Castiello, A.
    Visco, E.
    Papa, I.
    Dinatolo, E.
    Arabia, G. M.
    Nodari, S.
    EUROPEAN HEART JOURNAL, 2017, 38 : 855 - 855
  • [34] A Telemonitoring Program for Primary and Secondary Prevention of Cardiovascular Disease
    Nodari, Savina
    Lupi, Laura
    Glisenti, Fulvio
    Gensini, Gianfranco
    Papa, Ilaria
    Piazzani, Mariangela
    Fabbricatore, Davide
    Arabia, Gianmarco
    Gabbrielli, Francesco
    CIRCULATION, 2018, 138
  • [35] Inaccurate risk perceptions contribute to treatment gaps in secondary prevention of cardiovascular disease
    Thakkar, J.
    Heeley, E. L.
    Chalmers, J.
    Chow, C. K.
    INTERNAL MEDICINE JOURNAL, 2016, 46 (03) : 339 - 346
  • [36] Risk functions and the primary prevention of cardiovascular disease
    Grau, Maria
    Marrugat, Jaume
    REVISTA ESPANOLA DE CARDIOLOGIA, 2008, 61 (04): : 404 - 416
  • [37] Risk scoring for the primary prevention of cardiovascular disease
    Karmali, Kunal N.
    Persell, Stephen D.
    Perel, Pablo
    Lloyd-Jones, Donald M.
    Berendsen, Mark A.
    Huffman, Mark D.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (03):
  • [38] Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease
    Robson, J.
    HEART, 2008, 94 (10) : 1331 - 1332
  • [39] Risk Stratification in Patients with Ischemic Stroke and Residual Cardiovascular Risk with Current Secondary Prevention
    Gynnild, Mari Nordbo
    Hageman, Steven H. J.
    Dorresteijn, Jannick A. N.
    Spigset, Olav
    Lydersen, Stian
    Wethal, Torgeir
    Saltvedt, Ingvild
    Visseren, Frank L. J.
    Ellekjaer, Hanne
    CLINICAL EPIDEMIOLOGY, 2021, 13 : 813 - 823
  • [40] Gender-specific aspects of treatment of cardiovascular risk factors in primary and secondary prevention
    Lombardi, Mariaelena
    Mercuro, Giuseppe
    Fini, Massimo
    Rosano, Giuseppe M. C.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2010, 24 (06) : 699 - 705
12345